Future of the European Union regulatory network in the context of the uptake of new medicines

Authors

  • Joëlle M. Hoebert,

    1. Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands
    Search for more papers by this author
  • Alar Irs,

    1. Division of Clinical Pharmacology, University of Tartu, Tartu, Estonia
    2. Estonian State Agency of Medicines, Tartu, Estonia
    Search for more papers by this author
  • Aukje K. Mantel-Teeuwisse,

    Corresponding author
    • Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands
    Search for more papers by this author
  • Hubert G. M. Leufkens

    1. Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands
    2. Medicines Evaluation Board, Utrecht, the Netherlands
    Search for more papers by this author

CORRESPONDENCE

Mrs Aukje K. Mantel-Teeuwisse PharmD PhD, Utrecht Institute for Pharmaceutical Sciences (UIPS) Division of Pharmacoepidemiology and Clinical Pharmacology P.O. Box 80082 3508 TB Utrecht, the Netherlands.

Tel.: +31 30 253 7324

Fax: +31 30 253 9166

Email: a.k.mantel@uu.nl

Ancillary